chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Oct2022 as dose 5 (booster), single (Lot number: 956665) at the age of 65 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Lot number: EN6207), on 31Mar2021 as dose 2, single (Lot number: ER8737), on 31Oct2021 as dose 3 (booster), single (Lot number: FF2593) and on 22Apr2022 as dose 4 (booster), single (Lot number: FK9894) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "diverticulosis" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; LISINOPRIL; BABY ASPIRIN; CETRIZINE; VITAMIN D3 CALCIUM. Past drug history included: Perfluten lipid microspheres, reaction(s): "Drug allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Course of events: patient receive treatment with Paxlovid (lot # GG0050) started on 20Jan2023; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure / COVID-19 cannot be ruled out
This is a spontaneous report from a contactable physician received via a sales representative. An elderly female patient of an unspecified age (over 65 years old) and race/ethnicity received PREVNAR 13 on an unspecified date, at single dose, for immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced 12 cm by 12 cm large raised area showed up one week after injection, on an unspecified date, with unknown outcome.
arm pain; itching; It's become difficult to move her arm and has worsened since the injection/ I had a hard time lift my arm in changing clothes; It's become difficult to move her arm and has worsened since the injection/ I had a hard time lift my arm in changing clothes; I feel in my arm, around that shot you know I had the injection, start itchy start feel itchy; my arm feel pink, it's swell up and it's scratch; my arm feel pink, it's swell up and it's scratch; This is a spontaneous report from a contactable consumer (patient herself). A 77-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiry date not reported), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunisation. Medical history included bone disorder (reported as bad bone problem). Concomitant medication included denosumab (PROLIA) for bone disorder. The patient received her first injection on 09Jan2021 and had been experiencing arm pain which was mild to moderate but about a week later she developed itching in the same arm.  It's become difficult to move her arm and had worsened since the injection.  She wanted to know if this type of experience had been reported and if she should receive the second vaccination scheduled for the 30th. The patient stated that she had a hard time lift my arm in changing clothes and she can't her shoulder. After one week later about almost 1 week later she felt in her arm, around that shot she had the injection, started itchy started to feel itchy and she was afraid maybe infection, dead skin, maybe infection or something. She showed it to her friend, saying "Look my arm feel pink, it's swell up and it's scratch, it's itchy." Clinical outcome of event "difficulty to move her arm and had worsened since the injection" was not recovered while for the other events was unknown.
first dose of the moderna covid-19 vaccine and Today they received a dose of the Pfizer covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (first dose of the moderna covid-19 vaccine and Today they received a dose of the Pfizer covid-19 vaccine) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (first dose of the moderna covid-19 vaccine and Today they received a dose of the Pfizer covid-19 vaccine). On 03-Jun-2021, PRODUCT ADMINISTRATION ERROR (first dose of the moderna covid-19 vaccine and Today they received a dose of the Pfizer covid-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
Monovalent mRNA vaccine administered for a bivalent mRNA dose.   Had not been notified (as of date of this vaccine  administration)  that monovalent vaccine had been discontinued). Notice wasn't released from Department of Health and Human Services until 05-01-2023, sent via e-mail to my supervisor on 05-02-2023,  forwarded to me, where I read it the morning of  05-03-2023 at which time, then all remaining doses of monovalent mRNA vaccine was destroyed.  This patient had no adverse effects or event as result of this dose of vaccine given. Patient was given Pfizer Bivalent Vaccine Lot GJ 3270, on 05/17/2023 and tolerated well.
I just got diagnosed with acute pericarditis and it's just like I got it from the vaccination the COVID vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (medically significant), outcome "unknown", described as "I just got diagnosed with acute pericarditis and it's just like I got it from the vaccination the COVID vaccine".  Additional information: Additional Context: Concern: Consumer stated, "I just wanted to report that I just got diagnosed with acute pericarditis and it's just like I got it from the vaccination the COVID vaccine. I just wanted to call and report that so, that I can be reported in VAERS." When requested to probe further: Consumer stated, "You know I'm actually at the Doctor's office right now 'in return' can you call me back in about hour is that okay." LOT#: Consumer stated, "Not with me right now but when I call back I will provide back to you guys." Consumer was unwilling to complete the report. Further probing could not be done. Hence, limited information available over the call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient complained of feeling like he had water in his throat and his throat felt scratchy.  BP 126/62, Pulse OX 95  HR 100
her arms have been hurting all the way down and have a red spot itchy; her arms have been hurting all the way down and have a red spot itchy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "diabetic" (unspecified if ongoing); "contact dermatitis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), RASH MACULAR (non-serious), outcome "unknown" and all described as "her arms have been hurting all the way down and have a red spot itchy". Additional information: The patient said she got the coverage 2023 vaccine Friday morning (unspecified date) at a pharmacy name in her town and at night her arms have been hurting all the way down and have a red spot itchy. She said it didn't seem like an allergic reaction, but it kept getting worse she went to urgent care last night and was told by the pharmacist that this is a normal reaction and sometimes some people get it really big.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
For last several months knee pain had beensignificant & had recent knee injection,which provided no relief. As of yesterday morning, 3/29 I notice the joint pain, weakness and swellingthroughout body is gone.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis and multiple allergies. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included vitamin b nos (VITAMIN B), colecalciferol (VIT D3), ascorbic acid (VIT C) and probiotics nos (MANUFACTURER UNKNOWN), all taken for unknown indication since an unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine) via an unspecified route of administration in the right arm on 05Mar2021 at 02:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that, this was not adverse and was actually positive, but thought it should also be reported and don't see a place. From 09:00 to 16:00 the patient had fairly high pain level, largely concentrated in joints. The patient had suffered from trigger finger, ankle & wrist arthritis, meniscus prior meniscus surgeries for years. For last several months the patient had knee pain which had been significant & had recent knee injection, which provided no relief. As of previous day morning, on 29Mar2021, the patient noticed that the joint pain, weakness and swelling throughout body was gone. The patient reported that this could be of short term, but for now that was amazing. The patient's systemic joint issues began after a deep finger cut years ago that became inflamed. The patient had "no idea if vaccine killed another virus or what the hell was going on but, "yay".  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Administerd vaccine that was not stored in recommended temprature; A report was received from a health care professional concerning a 48-year old patient participating in the mRNA-1273 Emergency Use Program who was administered vaccine that was not stored in recommended temperature.  The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 (Lot 011J20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection on 21 Dec 2020. On the same day, the nurse noticed administered vaccine was not stored in recommended temperature. Temperature reading of -21.6 and -20.9 ranges were in Fahrenheit instead of Celsius as the freezer reading was set to Fahrenheit. The nurse called to inquire whether the vaccine is usable. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered vaccine that was not stored in recommended temperature, was unknown.   The reporter did not provide an assessment for the event of administered vaccine that was not stored in recommended temperature.; Reporter's Comments: This case concerns a 48-year-old subject who experienced the unlisted event of administered vaccine that was not stored in recommended temperature. The sponsor considers the event as Unassessable, because the event is a storage error.
Right after the vaccine I felt dizzy, confused and couldn't catch my breathe and very nauseas and a headache. I also felt the same after my 1st dose but it want as bad. The 2nd it hit immediately. I was struggling more than my typical migraine. The week before last, my heart was pounding and the felt arm was tingling and hurting and checked my BP and was out range  Went to the ER 10/3/2021 and 10/12/2021 ,last week chest pains, left arm was arm, a little into my neck . Hypokalemia, 2nd ER visit- I was resting, all of the sudden, I had pressure and pain in my chest. Called EMT from home - elevated BP 156/111 in hospital. Went to ER, kept overnight for observation. I had headache, nauseas and super dizzy.  I still feel extreme fatigue, nauseous and hard time concentrating .I am having a really hard time at work in nursing school.
I have been having significant burning and itching in my eyes. I assumed it was due to allergies, but I have been tested and it is not. It is irregular and hard to track cause. I did not think it could be related to the vaccine, then I was reminded this didn't start until after the vaccine.
Patient received the COVID vaccine on 12/30/2020.   Eight hours later, she c/o new onset of nausea, chills (shivering), and headache.  She states that it feels "weird". She is not herself. Still has shivering. Started to have sore throat on and off.  No runny nose, cough, or fever.  She also found out her co-worker tested positive today, 12/31/2020. Co-worker was vaccinated 1 week ago.
Within five minutes of getting the vaccine, I developed a hot flashes followed by a tickle in my throat. I then started coughing uncontrollably for several minutes. It resolved within 30 minutes and water.
THIS WAS AN ADMINISTRATION ERROR. THE PATIENT DID NOT HAVE ANY AE DURING THE TIME WE MONITORED HER. PATIENT PRESENTED TO THE MOBILE VACCINE CLINIC ON 6/15. SHE STATED SHE HAD NEVER RECEIVED A COVID VACCINATION AND THIS WOULD BE HER FIRST DOSE. SHE SELECTED MODERNA. 0.5 ML OF THE MODERNA VACCINE WAS ADMINISTERED. UPON ENTERING THE DOSE INTO ICARE, IT WAS DISCOVERED THAT THIS WAS ACTUALLY THE PATIENT'S 3RD DOSE. AS SUCH, THE BOOSTER DOSE OF 0.25 MG SHOULD HAVE BEEN ADMINISTERED. THERE WAS >=4 MONTHS SINCE HER SECOND DOSE. OF NOTE, SHE RECEIVED 2 DOSES OF PFIZER FOR HER PRIMARY SERIES, ACCORDING TO ICARE, WHICH WERE SPACED APPROPRIATELY.  PATIENT AGAIN PRESENTED TO THE MOBILE VACCINE CLINIC ON 6/22. SHE AGAIN STATED SHE HAD NEVER RECEIVED A COVID VACCINATION AND THIS WOULD BE HER FIRST DOSE. SHE AGAIN SELECTED MODERNA. 0.5 ML OF THE MODERNA VACCINE WAS ADMINISTERED. UPON ENTERING THE DOSE INTO I-CARE, IT WAS NOTICED THIS WAS ACTUALLY THE 4TH VACCINE DOSE, THUS 0.25 MG SHOULD HAVE BEEN ADMINISTERED. ADDITIONALLY, ONLY 1 WEEK HAD PASSED BETWEEN THE 2 DOSES. PATIENT DENIED ANY ADVERSE EVENTS FOLLOWING VACCINATION ON 6/15 AND 6/22.
11 hours after injection started with a burning sensation in upper back then flushing feeling with intermittent itchy from head to toe but especially in upper back and arms. Could see light redness on arms and shoulders but no hives or raised rash. Took Benadryl 25mg at 11:30 pm and 2:30 am along with ice packs on arms when it got worse. Also had a pressure feeling in upper back when trying to lie down or lie back in recliner along with congestion in back of throat. Breathing was never compromised. I was finally able to lie down in bed at 4 am on 12/31/20.
I started waking up about 6 am and had some chills.  I got up at 9:20 am and was extremely tired.  I had body aches, chills and extremely tired till about 9 pm.
She got the shot and we walked about 20 steps or so, and then she started having some blacked vision and blurred vision. She said she feels different but couldnt describe how she feels. I noticed she sweated. She sit and nurse put her feet at another chair. She tried walking after 30 minutes, she had to sit back again. After total of about 45 minutes of sitting, she felt normal and was able to walk and see normal
same day within 2 hours, nauseous , vomiting , loss of balance and fatigue, continuing for 2 days
Patient sx of worsening SOB. Initially admitted to a HCF from 7/22/23-7/26/23. Discharged home and readmitted to another Hospital on 8/7/23 for continued SOB and Pneumonia.
On 03-06-2021, when I received my second vaccine my left arm was again swollen, and my joints also were hurting.  Today I still have some pain shooting through where the vaccine was given to me on my left arm. I can say that it all started when I received the first vaccine on 02-06-2021. My left arm at the injection site was sore. I woke up middle of night, my joints and body aching. The next day, my joints were hurting more. On 02-08-2021, my left arm was slightly swollen from the joints to the elbow and it was also red at the injection site, and there was a red welch approximately 2 inches in diameter and I also developed nausea. On 02-10-21, I had diarrhea in the morning and my left shoulder was very red and bruised. The headache I experienced was like having fireworks, flashes of light would come and go.
18AUG96 rash, itching, diff walking, fever started advised to given DPH in ER;
12 hours after shot, chills, body aches, headache, fever 101.6 °F.  Took motrin and acetaminophen.
A Tetanus-Diptheria vaccine was administered on 03/27/01. The mother phoned into the office on 03/29/01 stating that the patient had experienced a deep aching pain in the left arm along with diarrhea, vomiting, temp, and chills on 03/27/01. The patient referred to physician.
Immunization given 12/7/2010, mother noticed 12/9/10 hard raised red area on (L) deltoid - size of tennis ball. Patient did not c/o pain unless laying on (L) side. 12/13/10 no signs of redness or hardness.
Syncope, blurred vision, tingling in hands and feet. Patient was seen in office - 5/24/17 and Hosp. ED - 5/25/17. Documents attached. Pt. is here due to nausea and dizziness since Monday night. Mom says that pt. has had episodes of dizziness since January. The patient presents with chest pain and Per triage note patient with chest pain that started this morning when he woke up before school. Patient went to school came home early because of his chest pain. Denies shortness of breath he does have some dizziness which she notices more often when he gets up quickly bends over. The dizziness is been going on for several days. The patient does have an appointment with the cardiologist on 6 June which is approximately 2 weeks. The mother brought the patient in because of the concern of the chest pain in the dizziness. Patient denies fever chills nausea vomiting or diarrhea. The onset was gradual and chronic. The course/duration of symptoms is fluctuating in intensity. Location: Left anterior inferior chest. Radiating pain: none. The character of symptoms is dull and achy. The degree at onset was minimal. The degree at maximum was minimal. The degree at present is minimal. Exacerbating factors consist of exertion, movement breathing. The relieving factor is rest. Associated symptoms: none.
This spontaneous report as received from a medical assistant refers to a 15 year old male patient. It was reported that patient received his first dose of GARDASIL (injection, strength, lot#, dose/frequency, route and duration were unspecified) on 10-JUN-2013 and just received a second dose of GARDASIL (injection, strength, lot#, dose/frequency, route and duration were unspecified) today, on 18-JUN-2013. No adverse effect reported. The outcome was unknown. Additional information has been requested.
Got 3rd dose; She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 046A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021). On 18-Aug-2021, EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021) had resolved.            No concomitant and treatment medication was reported by patient.  Patient reported that she was not immunocompromised. Patients had not experienced any other side effects.
I started feeling weakness, headache and muscle aches on 1/12 the day of 2nd dose of covid vaccine. On 1/13 I started feeling dizziness, headache and nausea that lasted until now (1/14).
Pt. states that after receiving the 2nd dose of Moderna 06/29/2021, started experiencing symptoms 07/06/2021 of coughing chest pains, and mucus. Primary tele-visit instructed to control at home.
Pt given DTAP in left thigh on 5/22/02 and became red and continues to be red despite cool compresses. Seen in office on 5/24/02 with left thigh erythema 5cm X 3cm area and induration over lateral surface with 2nd area of erythema over left inguinal area with 2cm lymphadenopathy. Dx'd with cellulitis and given Augmentin ES 600mg X 1 in office then put on Keflex 250mg tid X 10 days.
Received the ZOSTAVAX immunization injection on 06/22/2017 by pharmacist, in the left posterior upper arm. Developed a large uniformed dark red welt approx. 2-3 cm by 10 cm down to the elbow. It was both itchy and burning. Received treatment by Emergency facility. Diagnosed as cellulitis and prescribed KEFLEX 500 mg TID x 7 days. Reported to personal physician and VAERS. Administrated appeared to follow proper measure to insure sterility of needle and cleaned site properly. Had recent shower before injection. No discharge or increased redness at injection site.
Within a couple of months, I began getting chronic hives.  I have not been able to identify any other cause, but I have now been suffering with hives for two years since the second Moderna shot.   I take Allegra, which seems to keep them under control, but as soon as it wears off the hives come back.  I have never had issues with any allergies before except for occasional seasonal grasses.   I can only conclude that the vaccine may have made my immune system overreactive.